PTO- 1581 |
Approved for use through 12/31/2020. OMB 0651-0054 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88234661 |
LAW OFFICE ASSIGNED |
LAW OFFICE 127 |
MARK SECTION |
MARK |
THERAFLU (see, http://uspto.report/TM/88234661/mark.png) |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
THERAFLU |
OWNER SECTION (current) |
NAME |
GSK Consumer Healthcare S.A. |
MAILING ADDRESS |
Route de l'Etraz |
CITY |
Prangins |
ZIP/POSTAL CODE |
1197 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
Switzerland |
EMAIL |
XXXX |
OWNER SECTION (proposed) |
NAME |
GSK Consumer Healthcare S.A. |
MAILING ADDRESS |
Route de l'Etraz |
CITY |
Prangins |
ZIP/POSTAL CODE |
1197 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
Switzerland |
EMAIL |
XXXX |
CORRESPONDENCE INFORMATION (current) |
NAME |
Arrielle Millstein |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
trademarks@gsk.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
NOT PROVIDED |
CORRESPONDENCE INFORMATION (proposed) |
NAME |
Arrielle Millstein |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
trademarks@gsk.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
NOT PROVIDED |
DOCKET/REFERENCE NUMBER |
82765629 |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
009 |
CURRENT IDENTIFICATION |
Computer application software for mobile phones and handheld computers, namely, software for use in medical screening, testing and diagnosis of
influenza |
GOODS OR SERVICES |
KEEP ALL LISTED |
INTERNATIONAL CLASS |
010 |
CURRENT IDENTIFICATION |
Diagnostic apparatus for screening and detection of influenza for medical purposes |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
3 |
ONGOING EFFORT |
product or service research or development ; market research |
ALLOWANCE MAIL DATE |
07/16/2019 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
2 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
250 |
TOTAL AMOUNT |
250 |
SIGNATURE SECTION |
SIGNATURE |
/ASM/ |
SIGNATORY'S NAME |
Arrielle Millstein |
SIGNATORY'S POSITION |
Attorney for applicant, NY bar member |
DATE SIGNED |
01/07/2021 |
SIGNATORY'S PHONE NUMBER |
12013707293 |
SIGNATURE METHOD |
Sent to third party for signature |
FILING INFORMATION |
SUBMIT DATE |
Thu Jan 07 08:21:04 ET 2021 |
TEAS STAMP |
USPTO/ESU-XXX.XX.XX.X-202
10107082104182371-8823466
1-76044dbed21b8bda037b65d
9ab8219f111caf6baf943cb1f
08c39c6a9cefd2e09e-DA-210
38971-2021010707593035948
4 |
PTO- 1581 |
Approved for use through 12/31/2020. OMB 0651-0054 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: THERAFLU (see, http://uspto.report/TM/88234661/mark.png)
SERIAL NUMBER: 88234661
OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: GSK Consumer Healthcare S.A., having an address of
Route de l'Etraz
Prangins, 1197
Switzerland
Email: XXXX
Proposed: GSK Consumer Healthcare S.A., having an address of
Route de l'Etraz
Prangins, 1197
Switzerland
Phone:
Fax:
Email: XXXX
The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 07/16/2019.
For International Class 009:
Current identification: Computer application software for mobile phones and handheld computers, namely, software for use in medical screening, testing and diagnosis of influenza
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
For International Class 010:
Current identification: Diagnostic apparatus for screening and detection of influenza for medical purposes
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the third extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension
request: product or service research or development ; market research
Correspondence Information (current):
Arrielle Millstein
PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@gsk.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Correspondence Information (proposed):
Arrielle Millstein
PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@gsk.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all
official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $250 will be submitted with the form, representing payment for 2 classes.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /ASM/ Date Signed: 01/07/2021
Signatory's Name: Arrielle Millstein
Signatory's Position: Attorney for applicant, NY bar member
Signatory's Phone: 12013707293
Signature method: Sent to third party for signature
RAM Sale Number: 88234661
RAM Accounting Date: 01/07/2021
Serial Number: 88234661
Internet Transmission Date: Thu Jan 07 08:21:04 ET 2021
TEAS Stamp: USPTO/ESU-XXX.XX.XX.X-202101070821041823
71-88234661-76044dbed21b8bda037b65d9ab82
19f111caf6baf943cb1f08c39c6a9cefd2e09e-D
A-21038971-20210107075930359484